VBA
PRVA icon

Van Berkom & Associates’s Privia Health PRVA Stock Holding History

Van Berkom & Associates’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.5M Sell
3,711,623
-341,420
-8% -$7.91M 3.08% 6
2026
Q1 		$83.4M Buy
4,053,043
+208,787
+5% +$4.71M 2.71% 8
2025
Q4 		$91.1M Buy
3,844,256
+69,691
+2% +$1.7M 2.63% 10
2025
Q3 		$94M Buy
3,774,565
+873,344
+30% +$18.8M 2.72% 8
2025
Q2 		$66.7M Buy
2,901,221
+887,549
+44% +$20.6M 1.99% 33
2025
Q1 		$45.2M Buy
+2,013,672
New +$46.8M 1.45% 38

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Van Berkom & Associates's PRVA Position: Q2 2026 in Review

Van Berkom & Associates reduced its Privia Health (PRVA) stake by 8.4% in Q2 2026, selling an estimated $7.91M and leaving 3,711,623 shares worth $95.5M. The position accounts for 3.08% of the portfolio, ranked #6.

Van Berkom & Associates first reported a position in PRVA in Q1 2025 and has held it in 6 quarters since. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Van Berkom & Associates held 3,711,623 shares of Privia Health worth $95.5M as of Q2 2026.
  • Van Berkom & Associates sold 341,420 Privia Health shares in Q2 2026, an estimated $7.91M.
  • Privia Health made up 3.08% of Van Berkom & Associates's portfolio in Q2 2026, its #6 holding.
  • Van Berkom & Associates first reported a position in Privia Health in Q1 2025 and has held it in 6 quarters since.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Van Berkom & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.